Epidemiologic risk profile of infection with different groups of human papillomaviruses

Journal of Medical Virology

Volumn 81, Issue 9, 2009, Pages 1635-1644

  Chan, Paul K S ^a,c   Ho, Wendy C S ^a   Wong, Martin C S ^a   Chang, Alexander R ^b   Chor, Josette S Y ^a   Yu, Mei Yung ^a  

^a and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Cervical cancer; Chinese; Epidemiology; Human papillomavirus; Risk factors

Indexed keywords

ADULT; ARTICLE; CONTRACEPTION; EDUCATIONAL STATUS; FEMALE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; RISK FACTOR; SEXUALITY; SMOKING; STRUCTURED INTERVIEW; VIRUS DETECTION; VIRUS INFECTION; WART VIRUS;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; HONG KONG; HUMANS; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; RISK FACTORS; SEXUAL BEHAVIOR; SMOKING; YOUNG ADULT;

HUMAN PAPILLOMAVIRUS; PAPILLOMAVIRIDAE;

EID: 68949163161     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21575     Document Type: Article

References (40)

1. Castle PE, Schiffman M, Herrero R, Hildesheim A, Rodriguez AC, Bratti MC, Sherman ME, Wacholder S, Tarone R, Burk RD. 2005. A prospective study of age trends in cervical human papillomavirus acquisition and persistence in Guanacaste, Costa Rica. J Infect Dis 191:1808-1816. (Pubitemid 40705386)
2. Castle PE, Jeronimo J, SchiffmanM, Herrero R, Rodríguez AC, Bratti MC, HildesheimA, Wacholder S, Long LR, Neve L, Pfeiffer R, Burk RD. 2006. Age-related changes of the cervix influence human papillomavirus type distribution. Cancer Res 66:1218-1224. (Pubitemid 43165993)
3. Chan PK, Chan DP, To KF, Yu MY, Cheung JL, Cheng AF. 2001. Evaluation of extraction methods from paraffin wax embedded tissues for PCR amplification of human and viral DNA. J Clin Pathol 54:401-403.
4. Chan PK, Lam CW, Cheung TH, LiWW,Lo KW, Chan MY, Cheung JL, Cheng AF. 2002. Association of human papillomavirus type 58 variant with the risk of cervical cancer. J NatlCancer Inst 94:1249-1253. (Pubitemid 34993876)
5. Chan PK, Cheung TH, Tam AO, Lo KW, Yim SF, Yu MM, To KF, Wong YF, Cheung JL, Chan DP, Hui M, Ip M. 2006a. Biases in human papillomavirus genotype prevalence assessment associated with commonly used consensus primers. Int J Cancer 118:243-255. (Pubitemid 41681605)
6. Chan PK, Cheung JL, Cheung TH, Lin CK, Tam AO, Chan DP, Zhou DX, Lo KW, Yim SF, Siu SS. 2006b. HLA-B alleles, high-risk HPV infection and risk for cervical neoplasia in southern Chinese women. Int J Cancer 118:1430-1435. (Pubitemid 43306529)
7. Chan PK, Cheung TH, Lin CK, Siu SS, Yim SF, Lo KW, Cheung JL, Tam AO, Tang JW. 2007a. Association between HLA-DRB1 polymorphism, high-risk HPV infection and cervical neoplasia in Southern Chinese. J Med Virol 79:970-976.
8. Chan PK, Cheung JL, Cheung TH, Lin CK, Siu SS, Yu MM, Tang JW, Lo KW, Yim SF, Wong YF, To KF, Ng HK, Chung TK. 2007b. HLADQB1 polymorphisms and risk for cervical cancer: A case control study in a southern Chinese population. Gynecol Oncol 105:736-741. (Pubitemid 46738579)
9. Chan PK, Ho WC, Yu MY, Pong WM, Chan AC, Chan AK, Cheung TH, Wong MC, To KF, Ng HK. In press. Distribution of human papillomavirus types in cervical cancers in Hong Kong: Current situation and changes over the last decades. Int J Cancer. Published online 7 April 2009.
10. Clifford GM, Gallus S, Herrero R, Muñoz N, Snijders PJ, Vaccarella S, Anh PT, Ferreccio C, Hieu NT, Matos E, Molano M, Rajkumar R, Ronco G, de Sanjosé S, Shin HR, Sukvirach S, Thomas JO, Tunsakul S, Meijer CJ, Franceschi S, IARC HPV Prevalence Surveys Study Group. 2005. Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on CancerHPVprevalence surveys:A pooled analysis. Lancet 366:991-998.
11. Cogliano V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F, WHO International Agency for Research on Cancer. 2005. Carcinogenicity of human papillomaviruses. Lancet Oncol 6:204.
12. Cotton SC, Sharp L, Seth R, Masson LF, Little J, Cruickshank ME, Neal K, Waugh N, TOMBOLA Group. 2007. Lifestyle and sociodemographic factors associated with high-risk HPV infection inUK women. Br J Cancer 97:133-139. (Pubitemid 47012084)
13. Coutlée F, Gravitt P, Kornegay J, Hankins C, Richardson H, Lapointe N, Voyer H, Franco E. 2002. Use of PGMY primers in L1 consensus PCR improves detection of human papillomavirus DNA in genital samples. J Clin Microbiol 40:902-907. (Pubitemid 34208642)
14. Dai M, Bao YP, Li N, CliffordGM,Vaccarella S, Snijders PJ,Huang RD, Sun LX, Meijer CJ, Qiao YL, Franceschi S. 2006. Human papillomavirus infection in Shanxi Province, People's Republic of China: A population-based study. Br J Cancer 95:96-101. (Pubitemid 43980561)
15. de Sanjosé S, Diaz M, Castellsagué X, Clifford G, Bruni L, Muñoz N, Bosch FX. 2007.Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: A meta-analysis. Lancet Infect Dis 7:453-459. (Pubitemid 46962343)
16. de Villiers EM. 2003. Relationship between steroid hormone contraceptives and HPV, cervical intraepithelial neoplasia and cervical carcinoma. Int J Cancer 103:705-708.
17. de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H. 2004. Classification of papillomaviruses. Virology 324:17-27.
18. Ferreccio C, Prado RB, Luzoro AV, Ampuero SL, Snijders PJ, Meijer CJ, Vaccarella SV, Jara AT, Puschel KI, Robles SC, Herrero R, Franceschi SF, Ojeda JM. 2004. Population-based prevalence and age distribution of human papillomavirus among women in Santiago, Chile. Cancer Epidemiol Biomarkers Prev 13:2271-2276. (Pubitemid 40054329)
19. Franceschi S, Herrero R, Clifford GM, Snijders PJ, Arslan A, Anh PT, Bosch FX, Ferreccio C, Hieu NT, Lazcano-Ponce E, Matos E, Molano M, Qiao YL, Rajkumar R, Ronco G, de Sanjosé S, Shin HR, Sukvirach S, Thomas JO, Meijer CJ, Muñoz N. 2006. Variations in the age-specific curves of human papillomavirus prevalence in women worldwide. Int J Cancer 119:2677-2684. (Pubitemid 44691325)
20. Herrero R, Castle PE, Schiffman M, Bratti MC, Hildesheim A, Morales J, Alfaro M, Sherman ME, Wacholder S, Chen S, Rodriguez AC, Burk RD. 2005. Epidemiologic profile of type-specific human papillomavirus infection and cervical neoplasia in Guanacaste, Costa Rica. J Infect Dis 191:1796-1807. (Pubitemid 40705385)
21. Hong Kong Cancer Registry. 2008. Hospital Authority. Hong Kong Cancer Statistics 2007. Available at: http://www3.ha.org.hk/cancereg/eng/stat.asp. Retrieved 24 January 2008.
22. Katz MH. In: Silver P, editor. Multivariable analysis: A practical guide for clinicians. UK: Cambridge University Press. 2006. p. 74.
23. Kliucinskas M, Nadisauskiene RJ, MinkauskieneM. 2006. Prevalence and risk factors of HPV infection among high-risk rural and urban Lithuanian women. Gynecol Obstet Invest 62:173-180.
24. Klug SJ, Hukelmann M, Hollwitz B, Düzenli N, Schopp B, Petry KU, Iftner T. 2007. Prevalence ofhuman papillomavirus types inwomen screened by cytology in Germany. J Med Virol 79:616-625. (Pubitemid 46564361)
25. Lai HC, Sun CA, Yu MS, Chen HJ, Liu HS, Chu TY. 1999. Favorable clinical outcome of cervical cancers infected with human papilloma virus type 58 and related types. Int J Cancer 84:553-557.
26. Lin H,Ma YY, Moh JS, Ou YC, Shen SY, Chang Chien CC. 2006. High prevalence of genital human papillomavirus type 52 and 58 infection in women attending gynecologic practitioners in South Taiwan. Gynecol Oncol 101:40-45.
27. Matos E, Loria D, Amestoy GM, Herrera L, Prince MA, Moreno J, Krunfly C, van den Brule AJ, Meijer CJ, Muñoz N, Herrero R, Proyecto Concordia Collaborative Group. 2003. Prevalence of human papillomavirus infection among women in Concordia, Argentina: A population-based study. Sex Transm Dis 30:593-599.
28. Mayrand MH, Duarte-Franco E, Rodrigues I, Walter SD, Hanley J, Ferenczy A, Ratnam S, Coutlée F, Franco EL, Canadian Cervical Cancer Screening Trial Study Group. 2007. Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer. N Engl J Med 357:1579-1588.
29. McIntyre-Seltman K, Castle PE, Guido R, Schiffman M, Wheeler CM, ALTS Group. 2005. Smoking is a risk factor for cervical intraepithelial neoplasia grade 3 among oncogenic human papillomavirus DNA-positive women with equivocal or mildly abnormal cytology. Cancer Epidemiol Biomarkers Prev 14:1165-1170. (Pubitemid 40656462)
30. Muñoz N,Bosch FX, de Sanjosé S, Herrero R, Castellsagué X, Shah KV, Snijders PJ, Meijer CJ, International Agency for Research on Cancer Multicenter Cervical Cancer Study Group. 2003. Epidemiologic classification of human papillomavirus types associated with cancer. N Engl J Med 348:518-527.
31. Naucler P, RydW, Törnberg S, Strand A, Wadell G, Elfgren K, Rådberg T, Strander B, Johansson B, Forslund O, Hansson BG, Rylander E, Dillner J. 2007. Human papillomavirus and Papanicolaou tests to screen for cervical cancer. N Engl J Med 357:1589-1597. (Pubitemid 47598401)
32. Nielsen A, Kjaer SK, Munk C, Iftner T. 2008. Type-specific HPV infection and multipleHPVtypes: Prevalence and risk factor profile in nearly 12,000 younger and older Danish women. Sex TransmDis 35:276-282. (Pubitemid 351619532)
33. Peyton CL, Gravitt PE, Hunt WC, Hundley RS, Zhao M, Apple RJ, Wheeler CM. 2001. Determinants of genital human papillomavirus detection in a US population. J Infect Dis 183:1554-1564. (Pubitemid 32466692)
34. Rousseau MC, Abrahamowicz M, Villa LL, Costa MC, Rohan TE, Franco EL. 2003. Predictors of cervical coinfection with multiple human papillomavirus types. Cancer Epidemiol Biomarkers Prev 12:1029-1037. (Pubitemid 37310259)
35. Smith JS, Lindsay L, Hoots B, Keys J, Franceschi S, Winer R, Clifford GM. 2007. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: A meta-analysis update. Int J Cancer 121:621-632. (Pubitemid 46986496)
36. Thomas JO, Herrero R, Omigbodun AA, Ojemakinde K, Ajayi IO, Fawole A, Oladepo O, Smith JS, Arslan A, Muñoz N, Snijders PJ, Meijer CJ, Franceschi S. 2004. Prevalence of papillomavirus infection in women in Ibadan, Nigeria: A population-based study. Br J Cancer 90:638-645. (Pubitemid 38297204)
37. Tsai HT, Tsai YM, Yang SF, Wu KY, Chuang HY, Wu TN, Ho CK, Lin CC, Kuo YS, Wu MT. 2007. Lifetime cigarette smoke and secondhand smoke and cervical intraepithelial neoplasm-A communitybased case-control study. Gynecol Oncol 105:181-188.
38. Vaccarella S, Herrero R, Dai M, Snijders PJ, Meijer CJ, Thomas JO, Hoang Anh PT, Ferreccio C, Matos E, Posso H, de Sanjosé S, Shin HR, Sukvirach S, Lazcano-Ponce E, RoncoG,Rajkumar R, Qiao YL, Muñoz N, Franceschi S. 2006. Reproductive factors, oral contraceptive use, and human papillomavirus infection: Pooled analysis of the IARC HPV prevalence surveys. Cancer Epidemiol Biomarkers Prev 15:2148-2153. (Pubitemid 44877039)
39. Walboomers JM, Jacobs MV, Manos MM,Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Muñoz N. 1999. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189:12-19. (Pubitemid 29406813)
40. Wu RF, Dai M, Qiao YL, Clifford GM, Liu ZH, Arslan A, Li N, Shi JF, Snijders PJ,Meijer CJ, Franceschi S. 2007. Human papillomavirus infection in women in Shenzhen City, People's Republic of China, a population typical of recent Chinese urbanisation. Int J Cancer 121:1306-1311. (Pubitemid 47293798)